Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 4,812 | 0.0% | 33,930 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 4,894 | 0.0% | 34,865 | 9/30/2025 |
| 2025 Q2 | 7/31/2025 | 4,270 | 0.0% | 33,974 | 6/30/2025 |
| 2024 Q4 | 1/31/2025 | 5,214 | 0.0% | 38,196 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 4,401 | 0.0% | 38,196 | 9/30/2024 |
| 2024 Q2 | 8/7/2024 | 5,258 | 0.0% | 38,196 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 7,790 | 0.0% | 56,483 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 7,442 | 0.0% | 56,483 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 6,354 | 0.0% | 56,483 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 5,326 | 0.0% | 56,483 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 5,717 | 0.0% | 56,483 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 6,746 | 0.0% | 56,483 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 5,999 | 0.0% | 56,483 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 5,630 | 0.0% | 57,757 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 5,415 | 0.0% | 57,757 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 5,137 | 0.0% | 60,314 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 5,649 | 0.0% | 58,900 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 5,599 | 0.0% | 57,536 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 5,477 | 0.0% | 56,321 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 5,714 | 0.0% | 59,615 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 5,945 | 0.0% | 61,819 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 7,641 | 0.0% | 62,632 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 5,690 | 0.0% | 65,739 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 7,066 | 0.0% | 65,739 | 12/31/2019 |